Δ9-Tetrahydrocannabinol antagonizes endocannabinoid modulation of synaptic transmission between hippocampal neurons in culture
- 30 April 2004
- journal article
- Published by Elsevier BV in Neuropharmacology
- Vol. 46 (5), 709-715
- https://doi.org/10.1016/j.neuropharm.2003.11.005
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agentsBrain Research Reviews, 2003
- Despite substantial degradation, 2‐arachidonoylglycerol is a potent full efficacy agonist mediating CB1 receptor‐dependent G‐protein activation in rat cerebellar membranesBritish Journal of Pharmacology, 2001
- The endocannabinoid nervous system: Unique opportunities for therapeutic interventionPharmacology & Therapeutics, 2001
- Retrograde Inhibition of Presynaptic Calcium Influx by Endogenous Cannabinoids at Excitatory Synapses onto Purkinje CellsNeuron, 2001
- Neuropharmacology and therapeutic potential of cannabinoidsAddiction Biology, 2000
- Chronic ▵9‐Tetrahydrocannabinol Treatment Produces a Time‐Dependent Loss of Cannabinoid Receptors and Cannabinoid Receptor‐Activated G Proteins in Rat BrainJournal of Neurochemistry, 1999
- Endogenous Cannabinoid SignalingNeurobiology of Disease, 1998
- The CB1Cannabinoid Receptor in the BrainNeurobiology of Disease, 1998
- Modulation of Δ9‐tetrahydrocannabinol‐induced hypothermia by fluoxetine in the ratBritish Journal of Pharmacology, 1998
- Neurobiology of marijuana abuseTrends in Pharmacological Sciences, 1992